Identifying autoantigens in demyelinating diseases: Valuable clues to diagnosis and treatment?
Derfuss T, Meinl E. Identifying autoantigens in demyelinating diseases: valuable clues to diagnosis and treatment? Curr Opin Neurol. 2012;25(3):231-238
Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiple sclerosis
Kennel De March A, De Bouwerie M, Kolopp-Sarda MN, Faure GC, Béné MC, Bernard CC. Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiple sclerosis. J Neuroimmunol. 2003;135(1-2):117-125
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune mediated central nervous system demyelinating disorders: Revisions to the 2007 definitions
International Pediatric Multiple Sclerosis Study Group
Krupp LB, Tardieu M, Amato MP, et al. International Pediatric Multiple Sclerosis Study Group. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler. 2013;19(10):1261-1267
Antibodies to native myelin oligodendrocyte glycoprotein in children with Inflammatory demyelinating central nervous system disease
Brilot F, Dale RC, Selter RC, et al. Antibodies to native myelin oligodendrocyte glycoprotein in children with Inflammatory demyelinating central nervous system disease. Ann Neurol. 2009;66(6):833-842
Clinical and neuroradiological differences of pediatric acute disseminating encephalomyelitis with and without antibodies to myelin oligodendrocyte glycoproteins
Baumann M, Sahin K, Lechner C, et al. Clinical and neuroradiological differences of pediatric acute disseminating encephalomyelitis with and without antibodies to myelin oligodendrocyte glycoproteins. J Neurol Neurosurg Psychiatry. 2014;86(3):265-272
Distinction between MOG antibody-positive and AQP4 antibodypositive NMO spectrum disorders
Sato DK, Callegaro D, Lana-Peixoto MA, et al. Distinction between MOG antibody-positive and AQP4 antibodypositive NMO spectrum disorders. Neurology. 2014;82(6):474-484